| 584128 |
BMC CANCER |
A predictive nomogram for lymph node metastasis of incidental gallbladder cancer: a SEER population-based study |
2020-08-31 |
10.1186/s12885-020-07341-y |
Yang Yingnan, Tu Zhuolong, Cai Huajie, Hu Bingren, Ye Chentao, Tu Jinfu |
| 584127 |
BMB REPORTS |
Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner |
2020-08-31 |
10.5483/bmbrep.2020.53.8.031 |
Kim, Da-Hyun, Lee, Hyun-Woo, Park, Hyun-Woo, Lee, Han-Woong, Chun, Kyung-Hee |
| 584126 |
BMC CANCER |
Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study |
2020-08-31 |
10.1186/s12885-020-07339-6 |
Zhu Lucheng, Xu Zhizheng, Wu Yajun, Liu Pengyuan, Qian Jianing, Yu Shuhuan, Xia Bing, Lai Jianjun, Ma Shenglin, Wu Zhibing |
| 584125 |
PHARMACEUTICS |
Optimized Birch Bark Extract-Loaded Colloidal Dispersion Using Hydrogenated Phospholipids as Stabilizer |
2020-08-31 |
10.3390/pharmaceutics12090832 |
Mwiiri Francis Kamau, Daniels Rolf |
| 584124 |
BMB REPORTS |
Antibody-secreting macrophages generated using CpG-free plasmid eliminate tumor cells through antibody-dependent cellular phagocytosis |
2020-08-31 |
10.5483/bmbrep.2020.53.8.024 |
Cha, Eun Bi, Shin, Keun Koo, Seo, Jinho, Oh, Doo-Byoung |
| 584123 |
BMC CANCER |
Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study |
2020-08-31 |
10.1186/s12885-020-07327-w |
Choi Hayoung, Ko Yousang, Lee Chang Youl |
| 584122 |
PHARMACEUTICS |
Comment on Casiraghi et al. “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis” 2020, 12, 211 |
2020-08-31 |
10.3390/pharmaceutics12090829 |
Zur Eyal |
| 584121 |
BMB REPORTS |
Tumor necrosis factor-inducible gene 6 interacts with CD44, which is involved in fate-change of hepatic stellate cells |
2020-08-31 |
10.5483/bmbrep.2020.53.8.268 |
Wang, Sihyung, Kim, Jieun, Lee, Chanbin, Jung, Youngmi |
| 584120 |
BMB REPORTS |
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment |
2020-08-31 |
10.5483/bmbrep.2020.53.8.121 |
Jayaramayya, Kaavya, Mahalaxmi, Iyer, Subramaniam, Mohana Devi, Raj, Neethu, Dayem, Ahmed Abdal, Lim, Kyung Min, Kim, Se Jong, An, Jong Yub, Lee, Yoonjoo, Choi, Yujin, Kirubhakaran, Arthi, Cho, Ssang-Goo, Vellingiri, Balachandar |
| 584119 |
BMC CANCER |
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018) |
2020-08-31 |
10.1186/s12885-020-07268-4 |
Damato Angela, Iachetta Francesco, Antonuzzo Lorenzo, Nasti Guglielmo, Bergamo Francesca, Bordonaro Roberto, Maiello Evaristo, Zaniboni Alberto, Tonini Giuseppe, Romagnani Alessandra, Berselli Annalisa, Normanno Nicola, Pinto Carmine |
